Congratulations to Rachel Moen in the Ethan Lippmann research group! Rachel’s paper, 鈥淗ydrogel Embedding of Mesenchymal Stem Cells Supports Extracellular Vesicle Production,鈥�聽published in Biotechnology and Bioengineering, has been selected as this week鈥檚 Spotlight Publication.
Extracellular vesicles (EVs) derived from adherent cells are promising therapeutics for a wide variety of diseases. Previous studies have shown that mesenchymal stem cell (MSC)-derived EVs have many applications in wound healing and regenerative medicine. Specifically, MSC-derived EVs are safer than cell-based therapies because they do not involve the administration of live cells to patients. However, a lack of scalable workflows for producing EVs from 2D adherent sources is a major current limitation of the field. One proposed method for culture scale-up is to encapsulate MSCs in a gelatin methacryloyl (GelMA) hydrogel, which provides a 3D matrix that better mimics the in vivo microenvironment of human cells and can be shaped into spherical beads or thin films to support growth of shear-sensitive cells inside bioreactors. To establish proof of concept, we embedded MSCs in a layer of GelMA hydrogel to assess the production rate, molecular properties, and functional characteristics of EVs collected from 3D cultures. Hydrogel-encapsulated MSCs yielded a greater number of EVs per volume of culture compared to traditionally grown unencapsulated MSCs, and 3D cultures produced EVs with improved functionality in a scratch assay relative to vehicle treatment. These findings support the hypothesis that GelMA can be used to support scalable manufacturing of bioactive EVs from adherent cell sources.
Read full article in